TY - JOUR
T1 - Contemporary image-guided cervical cancer brachytherapy
T2 - Consensus imaging recommendations from the Society of Abdominal Radiology and the American Brachytherapy Society
AU - Jacobsen, Megan C.
AU - Beriwal, Sushil
AU - Dyer, Brandon A.
AU - Klopp, Ann H.
AU - Lee, Susanna I.
AU - McGinnis, Gwendolyn J.
AU - Robbins, Jessica B.
AU - Rauch, Gaiane M.
AU - Sadowski, Elizabeth A.
AU - Simiele, Samantha J.
AU - Stafford, R. Jason
AU - Taunk, Neil K.
AU - Yashar, Catheryn M.
AU - Venkatesan, Aradhana M.
N1 - Funding Information:
We thank Kelly Kage, MFA, CMI, Medical Illustrator at The University of Texas MD Anderson Cancer Center, for her assistance with the illustrations in this manuscript.
Publisher Copyright:
© 2022 American Brachytherapy Society
PY - 2022/7/1
Y1 - 2022/7/1
N2 - PURPOSE: To present recommendations for the use of imaging for evaluation and procedural guidance of brachytherapy for cervical cancer patients. METHODS: An expert panel comprised of members of the Society of Abdominal Radiology Uterine and Ovarian Cancer Disease Focused Panel and the American Brachytherapy Society jointly assessed the existing literature and provide data-driven guidance on imaging protocol development, interpretation, and reporting. RESULTS: Image-guidance during applicator implantation reduces rates of uterine perforation by the tandem. Postimplant images may be acquired with radiography, computed tomography (CT), or magnetic resonance imaging (MRI), and CT or MRI are preferred due to a decrease in severe complications. Pre-brachytherapy T2-weighted MRI may be used as a reference for contouring the high-risk clinical target volume (HR-CTV) when CT is used for treatment planning. Reference CT and MRI protocols are provided for reference. CONCLUSIONS: Image-guided brachytherapy in locally advanced cervical cancer is essential for optimal patient management. Various imaging modalities, including orthogonal radiographs, ultrasound, computed tomography, and magnetic resonance imaging, remain integral to the successful execution of image-guided brachytherapy.
AB - PURPOSE: To present recommendations for the use of imaging for evaluation and procedural guidance of brachytherapy for cervical cancer patients. METHODS: An expert panel comprised of members of the Society of Abdominal Radiology Uterine and Ovarian Cancer Disease Focused Panel and the American Brachytherapy Society jointly assessed the existing literature and provide data-driven guidance on imaging protocol development, interpretation, and reporting. RESULTS: Image-guidance during applicator implantation reduces rates of uterine perforation by the tandem. Postimplant images may be acquired with radiography, computed tomography (CT), or magnetic resonance imaging (MRI), and CT or MRI are preferred due to a decrease in severe complications. Pre-brachytherapy T2-weighted MRI may be used as a reference for contouring the high-risk clinical target volume (HR-CTV) when CT is used for treatment planning. Reference CT and MRI protocols are provided for reference. CONCLUSIONS: Image-guided brachytherapy in locally advanced cervical cancer is essential for optimal patient management. Various imaging modalities, including orthogonal radiographs, ultrasound, computed tomography, and magnetic resonance imaging, remain integral to the successful execution of image-guided brachytherapy.
KW - Cervical cancer brachytherapy
KW - Computed tomography
KW - Image-guided brachytherapy
KW - Magnetic resonance imaging
KW - Structured reporting
KW - Ultrasound
UR - http://www.scopus.com/inward/record.url?scp=85132909275&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85132909275&partnerID=8YFLogxK
U2 - 10.1016/j.brachy.2022.04.005
DO - 10.1016/j.brachy.2022.04.005
M3 - Article
C2 - 35725550
AN - SCOPUS:85132909275
SN - 1538-4721
VL - 21
SP - 369
EP - 388
JO - Brachytherapy
JF - Brachytherapy
IS - 4
ER -